Sulfamylon

Company
Mylan Laboratories

Approval Status
Approved June 1998

Treatment for
Burn Wounds

Areas
Dermatology / Plastic Surgery

Sulfamylon Powder for 5% solution has been approved for use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds. This is the first drug approved for this indication.

Sulfamylon Drug Information

The Sulfamylon drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top